According to Blueprint Medicines 's latest financial reports the company's current revenue (TTM) is C$0.49 B. In 2023 the company made a revenue of C$0.33 B an increase over the revenue in the year 2022 that were of C$0.27 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.